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quality of life in people with advanced
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Abstract
Background: During the past decade an increasing number of people live with advanced cancer mainly due to
improved medical treatment. Research has shown that many people with advanced cancer have problems with
everyday activities, which have negative impact on their quality of life, and that they spend a considerable part of
their time at home. Still, research on interventions to support the performance of and participation in everyday
activities is only scarcely available. Therefore, the occupational therapy-based “Cancer Home-Life Intervention”
consisting of tailored adaptive interventions applied in the participant’s home environment was developed.
The objective of this study is to examine the effectiveness and cost-effectiveness of the Cancer Home-Life
Intervention compared to usual care on the performance of and participation in everyday activities and
quality of life in people with advanced cancer living at home.
Methods: The study is a randomised, controlled trial (RCT) including an economic evaluation. The required sample size
of 272 adults living at home will be recruited from outpatient clinics at two Danish hospitals. They should be diagnosed
with cancer; evaluated incurable by the responsible oncologist; and with a functional level 1–2 on the WHO performance
scale. The primary outcome is the quality of performance of activities of daily living. Secondary outcomes are problems
with prioritised everyday activities; autonomy and participation; and health-related quality of life. Participants are
randomly assigned to: a) The Cancer Home-Life Intervention in addition to usual care, and b) Usual care alone.
Discussion: The trial will show whether the Cancer Home-Life Intervention provides better support for people
with advanced cancer living at home in performing and participating in everyday activities, and whether it
contributes to their health-related quality of life. The economic evaluation alongside the RCT will show if the
Cancer Home-Life Intervention is cost-effective. The trial will also show the acceptability of the intervention to
the target group, and whether subgroups of participants will benefit more than others.
Trial registration: ClinicalTrials.gov Identifier NCT02356627. Registered 02/02/2015.
Keywords: Palliative care, Supportive care, Health-related quality of life, Activities of daily living, Home based
intervention, Occupational therapy, Economic evaluation, Randomized controlled trial
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Background
The number of people living with advanced cancer is
increasing [1], and it is estimated that the majority of
these people are in need of palliative care [2, 3]. Accord-
ing to the World Health Organization (WHO), some of
the goals of palliative care are to alleviate adverse conse-
quences of the disease, to improve the quality of life,
and to help patients with life-threatening illness to live
as actively as possible [4]. Advanced cancer, defined as
cancer diagnosed as incurable by the responsible oncolo-
gist, can cause functional limitations [5, 6], which may
result in decreased ability and energy to perform every-
day activities, such as self-care, household, leisure and
work [7–9]. A recent study found that 48 % of patients
with advanced cancer (N = 977) had problems with
everyday activities, and that 29 % had unmet needs
regarding these [2]. In another study, more than 43 % of
women with metastatic breast cancer (N = 163) had
difficulties with activities of daily living (ADL) and 74 %
with instrumental activities of daily living (IADL) [10].
Further, in a study of people with advanced cancer,
10-30 % reported that they had needs in performing
everyday activities, i.e. activities that, in addition to
ADL and IADL, include leisure and work [11]. Con-
sequently, many people with advanced cancer are not
able to perform needed and desired everyday activ-
ities, which may lead to reduced quality of life for the
individual [12, 13].
Despite the knowledge about the problems and needs
of people with advanced cancer related to everyday
activities, palliative care rarely encompasses interven-
tions that focus on enabling everyday activities [14–16],
and little is known about how the everyday activities are
specifically affected and what kind of support is needed.
Prior to the present study, a cross-sectional study was
conducted to delineate the everyday activity problems,
particularly in regard to ADL performance, activities
prioritised to be solved, and intervention needs [17–19].
In all, 164 participants with an advanced cancer, a
mean age of 67 years, and a WHO Performance Sta-
tus of 1–3 were included. The findings showed that
many participants had functional limitations such as
fatigue and pain, and that their ADL performance
was characterised by increased effort and reduced ef-
ficiency, safety and independency. About half had ADL
motor ability below age expectations. The ADLs that
caused most problems were physically demanding activ-
ities such as cleaning, laundering, and cooking, while
fewer problems with self-care were found [18]. The study
showed that the everyday activities which the partici-
pants had problems with and prioritised being solved
mostly concerned leisure, social and domestic activ-
ities, along with a wish for improved mobility, autonomy
and participation [18].
A Danish randomised controlled trial (RCT) demon-
strated that an activity-focused hospital-based interven-
tion was feasible for people with advanced cancer [20].
The study did not identify superior effect of the interven-
tion partly due to a small sample size [21]. A systematic
review has indicated that home-based interventions can
improve health-related quality of life and satisfaction with
palliative care, reduce depressive symptoms, societal costs,
and the number of hospital admissions [22]. In addition, a
study has shown that people with advanced cancer spend
a considerable part of their time at home [23]. Hence a
home-based intervention may be more appropriate than a
hospital-based intervention in order to enable everyday
activities for people with advanced cancer.
We only identified one home-based intervention study
aimed at supporting everyday activities for people with
cancer. Hegel et al. performed a pilot RCT of a telephone-
delivered problem-solving occupational therapy interven-
tion lasting less than a mean time of 106 min. They found
that participation restrictions in everyday activities among
rural breast cancer patients undergoing chemotherapy
seemed to be decreased due to the intervention [24].
When searching for interventions for groups with activity
problems similar to those of people with advanced cancer,
such as people with chronic diseases and older people
with functional limitations, we only identified few studies.
The interventions mainly consisted of adaptation of every-
day activities, energy conservation, provision of assistive
or mainstream technologies, and home modifications,
resulting in improved functioning in everyday activities
and quality of life [25–29].
Based on the cross-sectional study, existing studies
and available guidelines, a literature review, and consult-
ation with representatives of the target group, the
“Cancer Home-Life Intervention” was developed and
pilot-tested. The intervention applies adaptive strategies,
defined as individual plans to overcome particular chal-
lenges or to meet the needs of the study participants
[30, 31], and aims to compensate for functional limi-
tations, enhance participation in everyday activities, and
support resource/energy preserving activity patterns of
people with advanced cancer. The intervention has under-
gone a small feasibility trial (N = 4) showing that the
intervention was acceptable for the study participants and
possible to implement. Since the Cancer Home-Life Inter-
vention is newly developed an evaluation of its effective-
ness and cost-effectiveness is required prior to wider
implementation. This study protocol outlines how we
intend to conduct such evaluation.
Study objective
The overall objective of this study is to examine the effect-
iveness and cost-effectiveness of the Cancer Home-Life
Intervention compared to usual care on the performance
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of and participation in everyday activities and health-
related quality of life in people with advanced cancer living
at home.
Specific aims
 To examine the effectiveness of the Cancer
Home-Life Intervention in terms of quality of
ADL performance as a primary aim and in terms of
problems with everyday activities prioritised to be
solved; autonomy and participation in the dwelling;
and health-related quality of life as secondary aims.
 To investigate whether the Cancer Home-Life
Intervention is especially effective in some
subgroups of people with advanced cancer defined
by age, gender, primary cancer diagnosis, and the
WHO Performance score.
 To explore how people with advanced cancer
experience the usefulness of the intervention, and
how activity patterns change over time in the two
groups.
 To investigate the cost-effectiveness of the Cancer
Home-Life Intervention.
Hypotheses
 The quality of ADL performance as demonstrated
by motor and process ability will be better in
participants undergoing the Cancer Home-Life
Intervention compared to participants who receive
usual care.
 Participants undergoing the Cancer Home-Life
Intervention will report less difficulty with priori-
tised everyday activities, better autonomy and par-
ticipation, and higher levels of health-related quality
of life compared to participants who receive usual
care.
 The Cancer Home-Life intervention provides more
Quality Adjusted Life Years (QALYs) at a higher in-
cremental cost.
 The Cancer Home-Life intervention is cost-effective
in a health sector perspective.
Methods
Trial design
The study is designed as a RCT using a combination of
quantitative and qualitative methods. A health economic
evaluation will be performed alongside the RCT.
Participants
Study participants will be enrolled consecutively from
Aarhus University Hospital (OUH) and Odense University
Hospital (AUH) in Denmark. Participants who fulfil the
following inclusion criteria will be enrolled in the study:
Inclusion criteria:
 ≥18 years old
 Diagnosed with cancer
 Evaluated incurable by responsible oncologist in
respective out-patient clinic
 Functional level 1–2 on the WHO performance
scale as assessed by hospital nurses or the project
occupational therapist (P-OT) [32]
 Live within a radius of maximum 60 km from AUH
or on the island of Funen
 Live in a private home or in sheltered living
 Know sufficient Danish to complete questionnaires
and participate in interviews
Exclusion criteria:
 Cognitive impairment preventing the participant to
complete the structured interview as assessed by a
P-OT during the interview prior to enrolment
 Live in a nursing home or a hospice
 Considered incapable of complying with the trial by
a P-OT
Enrolment procedure
At each participating hospital, nurses, secretaries, or the
Palliative Team will screen all potential participants for
inclusion in the study during 24 months. When eligible
participants are identified, the contact information is
given to a P-OT responsible for enrolment of study par-
ticipants. The P-OT will contact all potential participants
and provide detailed verbal and written information about
the study. Prior to inclusion, the study participants are to
give written permission.
Intervention and control
Intervention
The Cancer Home-Life Intervention is described in a
detailed intervention manual (unpublished, can be re-
trieved from the authors) and is provided by trained
Intervention Occupational Therapists (I-OT). The inter-
vention program is occupational therapy-based and
encompasses individually tailored combinations of the
following elements: 1) prioritisation of resources, energy,
and everyday activities; 2) adaptation of activities; 3) adap-
tation of posture and seating positioning; 4) provision of
assistive devices; 5) modification of the physical home
environment. Intervention elements are selected in co-
operation between the participant and the I-OT by means
of an interview with the participant based on the individ-
ual’s problems and needs. The intervention is provided
through instruction in and training of the selected
strategies, such as how to conduct activities in energy
conserving and strain minimizing ways, and guidance and
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training in safe and efficient use of assistive devices. It is
provided in the participant’s home within a week after
baseline data collection and completed within three weeks
after the initial home visit. The intervention will encom-
pass 1–3 home visits followed by 1–3 telephone calls.
When needed, the participant can also contact the I-OT.
In addition to the Cancer Home-Life Intervention, the
participants in the intervention group will receive usual
care as offered by the hospital and municipality. Usual
care aimed at enhancing everyday activities of people
with advanced cancer sometimes consists of provision
of assistive devices and home modifications, but not
necessarily provided systematically. All participants
will be allowed to use available medical services such
as rehabilitation and palliative care.
Four I-OTs, two at each hospital, will provide the
intervention after having attended a one-day training
course in the application of the Cancer Home-Life Inter-
vention. Regular meetings will be held with the I-OTs in
order to ensure that the intervention is applied accord-
ing to the manual and as similar as possible across
hospitals. The I-OTs will document adherence to the
intervention manual by registering which components of
the Cancer Home-Life Intervention they have provided
to each participant. The study participants will register
in a structured questionnaire which everyday activity
enabling interventions they have been offered and report
whether they have used them.
Control
Participants in the control group will receive usual care
as offered by the hospital and municipality, described
above.
Instrumentation
Primary outcome
Quality of ADL performance is measured by The Assess-
ment of Motor and Process Skills (AMPS) [33]. The
AMPS is a standardised, observation-based assessment
designed to evaluate the quality of a person’s ADL
performance regarding ease, efficiency, safety, and inde-
pendence. A trained and calibrated P-OT observes the
quality of 16 motor and 20 process performance skills
(ADL ability) while the person performs two familiar
and relevant ADLs, and rates the person’s performance
of each skill on a four-point ordinal scale. The ADL
motor ability is a measure of how much physical effort,
clumsiness, and/or fatigue the person demonstrates dur-
ing ADL performance. The ADL process ability is the
person’s overall efficiency regarding appropriate use of
time, space, and objects throughout ADL performance.
The ordinal scores are converted into two overall linear
ability measures by Rasch-based computer-scoring soft-
ware: one for ADL motor ability and one for ADL
process ability expressed in logistically transformed
probability units (logits). The two overall linear ability
measures are adjusted for task challenge, skill item diffi-
culty, and rater severity. ADL motor ability above 2.0
logits and ADL process ability above 1.0 logits indicate
competent ADL performance, and 0.3 logits a clinical
relevant change [33]. In the present study, the ADL
motor ability is used as the primary outcome. The P-OT
also assesses the five most effective and the five most
ineffective ADL motor and process skills based on clin-
ical reasoning [33]. The AMPS has been found valid and
reliable in people with advanced cancer [34, 35] and
responsive in people with other disorders [33].
Secondary outcomes
Problems with everyday activities prioritised to be solved
Problems with everyday activities at home that the partici-
pants face and prioritise to have solved, will be assessed
using the Individually Prioritised Problems Assessment
(IPPA) [36]. The instrument has a structured interview
format where the participant identifies up to seven every-
day activity problems and rates the importance of and
ease/difficulty with each of these problems on five-point
ordinal scales from 1 to 5, where 1 = not important at all
and 5 =most important; and 1 = no difficulty at all and 5
= too much difficulty to perform the activity at all. The
importance scores and the difficulty scores of each activity
are multiplied. The scores are then added up and divided
by the number of activity problems, resulting in an aver-
age IPPA score between 1 and 25. Higher average
IPPA scores indicate more difficulty with the priori-
tised everyday activities [36]. The IPPA has been found
to be a useful, responsive, and valid instrument in older
people who use assistive devices [37, 38].
Autonomy and participation in the dwelling
Autonomy and participation are assessed using three
subscales of the Danish version (IPA-DK) of the Impact
on Participation and Autonomy Questionnaire (IPAQ)
[39, 40]. The IPA-DK is a questionnaire targeting adults
with chronic functional limitations. It assesses person-
perceived participation restrictions via 32 items organised
into five subscales: 1. Autonomy indoors, 2. Family roles,
3. Autonomy outdoors, 4. Social life and relationships,
and 5. Work and education. For this study, the subscales
1, 2, and 4 are used. Response options are given on five-
point ordinal scales from 0 = very good to 4 = very poor.
In addition, there are nine items which quantify the de-
gree to which the respondents perceive these restric-
tions as problematic in their daily life. As these are
used for clinical decision making, they are not included in
this study. IPAQ is available in several language versions
which have well-documented psychometric properties,
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and the Danish version has undergone a reliability test
with satisfactory results [39].
Health-related quality of life
Health-related quality of life will be assessed by means
of The European Organization for Research Treatment of
Cancer Quality of Life Questionnaire Core 30 (EORTC
QLQ C-30) [41], designed to assess the health-related
quality of life of persons with cancer. The instrument
consists of nine scales assessing: physical function, role
function, emotional function, cognitive function, social
functioning, global health status/quality of life, fatigue,
nausea and vomiting, and pain, and six single-item scales:
dyspnoea, insomnia, lack of appetite, constipation, diar-
rhoea, and financial difficulties. All the scales and single-
item measures range in a score from 0 to 100. Higher
score represents a higher (“better”) level of function-
ing or a higher (“worse”) level of symptoms [41]. The
EORTC QLQ C-30 is a well-validated and reliable
instrument within cancer research [42, 43]. Addition-
ally, health-related quality of life will be measured by
the use of the EuroQol instrument (EQ-5D-5L) [44].
The EQ-5D-5L is a generic instrument measuring
health-related quality of life, and it is widely used in
economic evaluations. The instrument consists of five
dimensions: mobility, self-care, usual activities, pain/
discomfort and anxiety/depression. The participant scores
each dimension on a five-point ordinal scale ranging from
no problems to severe/extreme problems. A Danish set of
preference values was constructed based on interviews
with 1332 Danish respondents [45]. The psychometric
properties of the EQ-5D-5L including the Danish version
have been extensively investigated and are considered as
good [46]. The data from the EQ-5D-5L will be used for
the economic evaluation alongside the RCT.
Descriptive data
Everyday activity pattern
The everyday activities that the participants engage in
during a day will be captured by the Time Geographical
method using a semi-structured diary [47]. The partici-
pants will be required to record the activities they
undertake during one day of their own choice. The diary
encompasses domains regarding which activities the
participants engage in during the day, at what time, for
how long, whom they are with, where they are, and how
they feel physically and mentally [47].
Joyful activities
As a way to better understand what activities are of
importance to the participants they are asked which
everyday activities they regard as especially joyful [48].
Experienced usefulness
Participant observations will be conducted during 10–20
intervention sessions depending on the number of inter-
ventions provided for the individual participants [49].
In addition, telephone interventions provided to this
sub-sample will be electronically recorded. In particu-
lar, attention will be on the participants’ reactions to
the intervention as it takes place.
Qualitative interviews will be conducted in conjunc-
tion with data collection at follow-up in the participants’
homes. The interviews that will explore the usefulness of
the intervention will be based on an interview guide
developed from a preliminary analysis of the previous
participant observations to acquire the participants’ ex-
periences of the intervention received and its usefulness.
Cost data
Intervention costs
The intervention costs will be measured based on micro
costing including occupational therapists’ and study par-
ticipants’ time spent on the intervention; the costs for
applications and assistive devices and home modifica-
tions; the occupational therapists’ time used for related
administrative purposes and transportation.
Costs in the secondary health care sector
The costs of secondary health care will be determined
by Diagnostic Related Group (DRG) tariffs extracted
from the National Patient Registry (NPR). The data
include information on hospital departments, dates of
admission and discharge, and diagnosis [50].
Costs in the primary health care sector
Data on the use of primary health care including contacts
to general practitioners, medical specialists, and physio-
therapists will be extracted from The Danish National
Health Service Register for Primary Care (NHSR) and
valued using the activity-based fees that are used to reim-
burse these providers. The NHSR contains information
about the activities of health professionals’ contacts with
the tax-funded public health care system [50].
Prescriptive medication
Data on the use of prescriptive medication will be
extracted from the Danish National Register of Prescrip-
tive Medication. This database includes information on
all redeemed prescriptive medication and the associated
costs.
Study participants’ out-of-pocket costs
Out-of-pocket costs such as non-prescriptive medica-
tion, dietary supplements, informal care, aids, and short
term sick leave are assessed using a modified version of
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the Dutch cost diary [51]. The patient out-of-pocket
costs will solely be included in the sensitivity analysis.
Productivity costs
This will be calculated using data on the number of
weeks of sick leave obtained from the Danish Register
for Evaluation of Marginalization (DREAM), which is
administered by the Danish Ministry of Employment.
This database includes information on all public transfer
payments for all Danish citizens registered on a weekly
basis since 1991 [52]. The productivity costs per study
participant will be calculated using the Human Capital
method [53]. Productivity costs will solely be included in
the sensitivity analysis.
Sample size
Two hundred and seventy two participants will be en-
rolled. The sample size calculation was based on the mean
ADL motor ability as identified in the cross-sectional
study to be 1.04 logits with a standard deviation (SD) of
0.727 logits [18]. For a two-sample t-test of normal distri-
bution with a two-sided significance level of 0.05 and a
common SD of 0.727, a sample size of 184 participants
(92 per group) would provide 80 % power to detect a
between-group difference of 0.3 logits [33]. To achieve
this number, the study needs a total of 272 participants
(136 per group), expecting a dropout rate based on previ-
ous studies of 32 % at 12 weeks follow-up [14, 16, 24, 54].
A sub-sample of ten participants will be recruited
among the entire sample using purposive sampling for
participant observations during intervention sessions
and for qualitative interviews [48]. Specific criteria for
selection will be defined prior to actual sampling.
Data collection
Data will be collected at baseline (T1) by means of a
study specific questionnaire (demography, health, cost
diary, the IPA-DK, EORTC QLQ C-30, and the EQ-5D-
5 L) and the One Day Diary. The questionnaire and the
One Day Diary are sent out before a home visit by the
P-OTs, where the AMPS and IPPA are applied, and a
question about joyful activities and one about how they
manage their everyday life are asked. In addition, data
concerning use of assistive devices using a study specific
questionnaire are collected. The two ADLs that the par-
ticipant will perform for the AMPS observation are se-
lected on basis of the One Day Diary and the IPPA data.
See Fig. 1 and Table 1. The quality of AMPS data will be
monitored by Center for Innovative OT Solutions, USA,
and only valid data will be included.
There will be three follow-up occasions where cost data
from registers are also extracted, while demographic data
are only collected at T1:
T2) Six weeks after T1: a postal questionnaire identical
to the one sent out at T1 and a study specific question-
naire on the type of interventions both groups have
received and/or completed. Besides, an IPPA telephone
interview is accomplished.
T3) 12 weeks after T1: identical to T1 except that a
question whether their everyday life has improved is also
asked.
T4) 24 weeks after baseline: a postal questionnaire that
includes the cost diary and the EQ-5D-5L.
Observation based data are collected in conjunction
with the intervention, and qualitative interviews with
a subsample are accomplished at T3.
Randomisation
Study participants will be randomly assigned to either
the intervention group (receiving the Cancer Home-Life
Intervention as a supplement to usual care) or the
control group (receiving usual care and not receiving the
Cancer Home-Life Intervention). See Fig. 1.
Randomisation will be carried out after T1 by an
administration office, which is independent of the trial.
Participants will be randomly assigned in a preset block
size to either the intervention or control group with a
1:1 allocation by a computer-generated randomisation
schedule. The block size will be kept unknown to all
investigators and P-OTs and will not be revealed until
the study has ended. The randomisation is stratified by
centre.
Blinding
Allocation is concealed to the study investigators. The
P-OTs will also be sought blinded for the group allo-
cation even though they may discover this when col-
lecting follow-up data, and the study participants are
told not to reveal their group allocation to the P-OTs
during the follow-up occasions. At T3 the P-OTs will
be asked to guess the group allocation of the partici-
pants. This may indicate if the blinding has suc-
ceeded. Allocation status cannot be blinded for the
participants.
Analysis
Data analyses of the clinical evaluation
Scores will be calculated following the instructions in
each instrument manual and presented by descriptive
statistics. The intervention group will be compared with
the control group by means of a multiple linear regres-
sion analysis in continuous data (AMPS, EORTC QLQ
C-30 and IPPA), given the assumptions are fulfilled. If
the assumptions are not met, a relevant transformation
or logistic regression will be used. IPA-DK data are
ordinal and will be dichotomised before logistic regres-
sion analysis is applied. The analysis of all outcomes will
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be adjusted for the stratification variable, centre. If
there is significant imbalance between the two groups
we shall consider adjusting for baseline ADL motor
ability, baseline ADL process ability, gender, age, primary
cancer diagnosis, education, employment and the EORTC
QLQ-C30 global health status/quality of life in a sensitiv-
ity analysis [55, 56]. The between-group differences in
continuous and dichotomised data will be presented with
95 % confidence intervals. A complete case analysis ex-
cluding participants without post-randomisation data will
be performed [57]. It will be supplemented with a sensitiv-
ity analysis applying multiple imputation used to estimate
a plausible value for the missing data of study participants
lost to follow-up of other reasons than death [58].
Analyses will be performed to identify groups in which
the Cancer Home-Life Intervention is especially effective.
A subgroup-treatment effect interaction by a multiple
regression analysis will be performed with the following
possible variables as effect modifiers: age, gender, primary
cancer diagnosis and WHO Performance score [59, 60].
P values ≤0.05 will be considered statistically signifi-
cant. Analyses will be performed using STATA.
The One Day Diary data from T1 and T3 will be
coded thematically into the following structure: 1) The
activity domain comprising seven categories: self-care;
care for others; household; leisure; transportation; pro-
curement and preparation of food; and work. 2) The
geographical domain: location and movements. 3) The
social context: social circle and interaction. 4) The ex-
periential domain: physical state and state of mind. The
analyses will be used to describe the study participants’
daily activities with regard to each domain including
duration and frequency of activities as well as activity
patterns for the individual over the time of a day [47].
Field notes from the participant observations will be
transcribed into a coherent text. Interviews will be
Fig. 1 Randomisation and data collection
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transcribed verbatim. Both data sets will be analysed by
thematic analysis to unfold and understand how the
participants reacted to and experienced the usefulness of
the received interventions, and to explore how the
intervention worked and what aspects had particular
relevance for the participants [48]. Thereafter, data de-
rived from participant observations and interviews will
be analysed with a constant comparative method. The
analysis involves comparing different types of data from
the two methods in order to systematically trace out
categories and relationships within the data [61].
Data analysis for the economic evaluation
The economic evaluation will be conducted as a cost-
effectiveness analysis. A health sector viewpoint will be
taken to estimate the costs of all activities and resource
use related to the study participants’ disease. T1 will be
taken as the start of the time frame that will end at T4.
All costs will be reported in 2015-Euros. By the use of
register data to estimate costs, we expect a full follow-up
of these data. The method of multiple imputation [58]
will be used to handle possible lost to follow-up in the
ADL motor ability or the EQ-5D-5L due to other
reasons than death.
In the cost-effectiveness analysis the ADL motor
ability will be used as the clinical parameter and QALY
will be used as the measure of utility. In order to calcu-
late QALY the EQ-5D-5L the recommended standard
mapping procedure will be used based on the Danish
preference weights [45]. The QALYs over 24 weeks will
be calculated by interpolation of the area under the
curve with four time points (T1, T2, T3, and T4). The
resource use, costs, and clinical outcome will be pre-
sented as means with 95 % bootstrapped confidence
intervals (10,000 replicates) [62]. The Incremental Cost-
Effectiveness Ratio (ICER) will be calculated using the
formula: ICER = (CA – CB) / (EA – EB), where C denotes
costs and E denotes effects with A and B referring to
comparators. The ICER summarises the results of each
economic evaluation in a single parameter, defined as
the ratio of additional costs per additional unit of effect
[53]. The ICER is, however, undefined if the ratio or just
one of the confidence limits is negative.
The result of the cost-effectiveness analysis will be
summarised in cost-effectiveness acceptability curves
(CEAC) [63]. A CEAC is a graphic representation of the
uncertainty in cost differences and effect differences
between the two groups [63]. To deal with the structural
uncertainties, sensitivity analysis will be performed to
test the influence of the chosen imputation strategy.
Further sensitivity analysis will be performed to test the
inclusion of productivity costs and patients’ out-of-pocket
payments [53].
Ethical considerations
All participants enrolled in the project will receive writ-
ten and oral information about the project procedures
and will have volunteered to participate, which will be
verified by written consent. All eligible participants will
be informed that they are free to withdraw from the
Table 1 Schedule for collection of outcomes and cost data
Outcome Source Data collection
method
Baseline
T1
Week 6
T2
Week 12
T3
Week 24
T4
Everyday activities
Quality of ADL performance AMPS Observation X X
Problems with everyday activities IPPA Structured interview X X X
Autonomy and participation IPA-DK Questionnaire X X X
Health-related Quality of Life
Health-related quality of life EORTC QLQ C-30 Questionnaire X X X
Economic evaluation
Quality Adjusted Life Years (QALY) EQ-5D-5L Questionnaire X X X X
Intervention costs Questionnaire X
Costs in the secondary health care sector The National Patient Registry Register X X X X
Costs in the primary healthcare sector The Danish National Health Service
Register for Primary Care
Register X X X X
Prescriptive medication Danish Register of Prescriptive Medication Register X X X X
Out-of-pocket costs Cost diary X X X X
Productivity costs The Danish Register for Evaluation of
Marginalization
Register and
questionnaire
X X X X
AMPS The Assessment of Motor and Process Skills, EORTC QLQ-C30 The European Organization for Research Treatment of Cancer Quality of Life Questionnaire
Core 30, EQ-5D-5L The EuroQol 5-dimensions 5 levels, IPA-DK The Danish version of the Impact on Participation and Autonomy Questionnaire (IPAQ), PPA, The
Individually Prioritised Problems Assessment
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study at any time without consequences for their future
care. The trial will be conducted in accordance with the
ethical principles outlined in the Declaration of Helsinki
2008 [64]. According to the Danish Regional Scientific
Ethical Committee regulations the project is not notifi-
able, because no human biological material is included
in the project (S-20122000-96). Permission to obtain
and store data was originally given by the Danish Data
Protection Agency (J.nr. 2012-41-1404), but controller-
ship has later (March 27 2015) been transferred to the
umbrella/joint notification of Southern Denmark to the
Danish Data Protection Agency of University (FN 215-
57-0008). The intervention group will be treated by
authorised occupational therapists trained specifically
for the present study. Since the control group will be
offered the care that is usually given, and the outcome of
the Cancer Home-Life Intervention is expected to have
a positive impact on the everyday activities of people
with advanced cancer, allocation to either the control
group or the intervention group is ethically acceptable.
No adverse effects of the planned intervention are ex-
pected. However, because the participants suffer from a
life-threatening disease, the assessments may cause emo-
tional reactions [65]. This will be handled in an ethically
appropriate manner: all participants will receive a tele-
phone number so that they can contact the research
team if needed, and time is allocated for the P-OTs and
the I-OTs to talk to the participants if required. All
results will be handled confidentially, and only group
results will be published.
The project is approved by the Danish Data Protection
Agency (J.nr. 2012-41-1404). Data will be stored in locked
filing cabinets or in password-protected computers at the
University of Southern Denmark, archived in accordance
with University guidelines and the Danish Data Protection
Agency.
The study is registered in www.controlled-trials.com/
ClinicalTrials.gov (NCT02356627).
Discussion
The present study will contribute with knowledge about
whether the Cancer Home-Life Intervention can support
people with advanced cancer living at home in perform-
ing and participating in prioritised everyday activities,
and whether the intervention contributes to their health-
related quality of life. So far knowledge about improving
and preserving everyday activities of people with advanced
cancer is scarce. Given that these people live longer and
are increasingly receiving medical treatment on an out-
patient basis, they need to be able to manage or live an
everyday life according to their own wishes; there is a
definite need for such knowledge.
A strength of the study is that parts of it are based on
the previous cross-sectional study serving as a kind of
feasibility study as recommended by The Medical Re-
search Council [66]. For instance we gained experience
with ways of recruiting from hospitals, time use and
procedures for data collection; we got knowledge about
the demographics and clinical characteristics of the
study population and which everyday activities they had
problems with, and which they would like to have solved.
Most importantly the cross-sectional study provided em-
pirical information that could be used to calculate the
sample size on basis of our primary outcome measure.
The calculation was therefore based on the required num-
ber of participants at T3, taking expected drop-out into
account in order to get sufficient power to detect possible
effects. Another strength is that we involved a patient
expert group consisting of representatives of people with
advanced cancer to advise us about the contents and feasi-
bility of the Home-Life Intervention and piloted the pro-
cedures and the intervention prior to trial start (N = 4).
One of the challenges encountered in the cross-
sectional study was the mortality of the study population.
For instance only ten of the 84 study participants included
from OUH were alive one and a half year after completion
of the cross-sectional study. The consequence may be that
a substantial part of the study participants may not be
alive at the 24 weeks’ follow-up (T4). Since data from T4
are solely used for the economic evaluation and mostly
consist of register based data, it still is possible to get
useful results.
The study is one of the first to investigate the effect of
everyday activity interventions for people with advanced
cancer in the home. In addition to data on the effective-
ness of the Cancer Home-Life Intervention, the study
will provide information about the cost-effectiveness of
the intervention, its acceptability for the target group,
and whether some subgroups might benefit more than
others from the intervention. Hence the study will yield
comprehensive knowledge that can be applied in pallia-
tive care in case of positive results; if so, the next step
will be to investigate how to implement the Cancer
Home-Life Intervention in municipality palliative care.
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